Hole out
To be dismissed by being caught, usually referring to a catch from a lofted shot (or attempt thereof) in the outfield or forward from the wicket, rather than being caught behind by the wicketkeeper, in the slips cordon, or a leg trap fielder from edges or gloved balls. Hoodoo
a bowler is said to have the hoodoo on a batsman when they have got them out many times in their career. (See rabbit II.) Hook
a shot, similar to a pull, but played so that the ball is struck when it is above the batsmans shoulder. Hoop
a particularly large amount of swing. Hot Spot
a technology used in television coverage to evaluate snicks and bat-pad catches. The batsman is filmed with an infrared camera, and friction caused by the strike of the ball shows up as a white "hot spot" on the picture. Howzat or Hows that? See appeal

Hundred
1. See century
2. 100-ball cricket, a limited overs format with modified rules, such as each team batting for up to 100 legal balls, to speed up the game for television broadcasters. 3. The Hundred, a domestic competition in England that uses the 100-ball format, introduced in 2021. Hutch
the pavilion or dressing room. Non-specialist batsmen or tail enders can be known as rabbits, so when they are given out they return to the hutch. I
In
of a batsman, presently batting. In/out field
The in/out field is the group of fielders close to the batsman or closer to the boundary respectively.
Blue blocking screen protectors can help provide relief from symptoms caused by televisions, phones, tablets and computer screens. EPP is considered one of the least severe of the porphyrias. Unless there is liver failure, it is not a life-threatening disease. Approved therapies
Afamelanotide, developed by Australian-based Clinuvel Pharmaceuticals, was approved in Europe in December 2014 and in the United States in October 2019 for treatment or prevention of phototoxicity in adults with EPP. Off-label therapies
Several drugs are used off label by patients with EPP:

Ursodeoxycholic acid is a bile acid that is administered to promote biliary secretion of protoporphyrin. Results of its use in EPP are controversial. However, it is known to alter the composition of bile, to protect hepatocytes from the cytotoxic effect of hydrophobic bile acids, and to stimulate biliary secretion by several distinct mechanisms. Hematin appears to reduce excess protoporphyrin production in the bone marrow. It has been administered to patients with EPP (3–4 mg/kg iv) who develop a crisis after liver transplantation. Plasmapheresis can also decrease the levels of protoporphyrin in plasma, however its use in treating acute episodes is controversial. Cholestyramine is an orally administered resin which reduces circulating levels of protoporphyrin by binding to protoporphyrin in the intestine and, hence, interrupting the enterohepatic circulation. It is usually used in combination with other treatment approaches. Activated carbon, like cholestyramine, binds to protoporphyrin in the intestine and prevents its absorption. It is cheap and readily available.